Chen, Ni <br/><br/>
Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma.  [electronic resource] 

 -  Molecular cancer  Jul 2015 
 - 140 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/s12943-015-0418-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--complications<br/>Adenocarcinoma of Lung<br/>Animals<br/>Bevacizumab--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--complications<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lung Neoplasms--complications<br/>Mice<br/>Plasminogen Activator Inhibitor 1--biosynthesis<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Venous Thromboembolism--chemically induced<br/>Xenograft Model Antitumor Assays